NCT02154542

Brief Summary

Mechanical ventilation is a vital therapeutic support, widely used in pediatric intensive care. Invasive ventilation (IV) is associated with risk of major complications ( nosocomial pneumonia, secondary pulmonary barotrauma injuries, pneumothorax) , which can increase : the duration of ventilation, mortality, length of ICU stay and health costs. The practitioner should ask the benefit of the continuation of this IV daily and adapting it, to limit complications. The evaluation of the work of breathing is a key element in understanding the pathophysiology of respiratory distress but is also a key element in improving the management of ventilatory support and the adjustment of ventilatory parameters . It has been shown that there is an increased work of breathing in all children admitted in ICU for clinical acute respiratory distress that is significantly reduced by ventilatory support. There is probably a relationship that should be proportional between the work of breathing ( PTP ) resulting in respiratory request triggered by the respiratory drive and the electrical activity of the diaphragm ( Edi ) . The validation of this correlation PTP / Edi has a direct impact on the monitoring of ventilated patients with the ability to monitor the physiological factor while maintaining a classical treatment of children by simply monitoring Edi without additional invasive device .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 13, 2014

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 3, 2014

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

November 23, 2015

Status Verified

November 1, 2015

Enrollment Period

11 months

First QC Date

May 13, 2014

Last Update Submit

November 20, 2015

Conditions

Keywords

NavaMechanical ventilation

Outcome Measures

Primary Outcomes (1)

  • The correlation between diaphragmatic electrical activity (edi) and the work of breathing assessed by measuring the oesophageal pressure time product (PTP) during mechanical ventilation weaning

    within 12 hours of extubation

Secondary Outcomes (2)

  • Measure of the asynchrony index (AI) during NAVA and standard mode. Comparison of AI and PTP between NAVA and standard mode

    within 12 hours of extubation

  • Rate profile of Edi and PTP as a predictor of success or failure of the withdrawal

    within 48 hours after extubation

Study Arms (2)

Experimental A

ACTIVE COMPARATOR

NAVA then standard mode

Device: Neurovent Monitor XIII

Experimental B

ACTIVE COMPARATOR

Standard mode then NAVA

Device: Neurovent Monitor XIII

Interventions

Also known as: Health Canada approval number: 209799
Experimental AExperimental B

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Up to 18 years
  • Child on invasive mechanical ventilation for which the withdrawal phase was determined by the clinician in charge of the patient
  • Consent obtained

You may not qualify if:

  • Post conceptional age \< 37 weeks
  • Contraindication to changing or insertion of nasogastric tube (esophageal malformation, gastrointestinal bleeding, esophageal varices)
  • Curarised patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Justine's Hospital

Montreal, Quebec, H3T 1C5, Canada

Location

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • Guillaume Emeriaud, MD, PhD

    St. Justine's Hospital

    PRINCIPAL INVESTIGATOR
  • Philippe Jouvet, MD, PhD

    St. Justine's Hospital

    PRINCIPAL INVESTIGATOR
  • Sandrine Essouri, M.D, Ph.D.

    St. Justine's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

May 13, 2014

First Posted

June 3, 2014

Study Start

October 1, 2013

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

November 23, 2015

Record last verified: 2015-11

Locations